Clinical Trial Update: Docetaxel in Treating Children With Recurrent Solid Tumors [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating docetaxel in children with recurrent solid tumors has completed; results are summarized in the update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain and Central Nervous System Tumors
• Neuroblastoma
• Sarcoma

Drugs mentioned

• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Brain and Central Nervous System Tumors, Neuroblastoma | Phase 2 | Status: COMPLETED